Marcel Van Gaalen

This inventor holds 11 USPTO granted patents and 4 published patent applications and 4 EPO patents. Top assignees: Abbvie Deutschland Gmbh and Co Kg, Abbvie Inc.. Active years: 2015-2018.

USPTO Granted Patents = 11 (Patent Applications = 4)

% Patents Active = 45.5

EPO Patents = 4 (Patent Applications = 9)

Average Co-Inventor Count = 6.7

ph-index = 3

Forward Citations = 18(Granted Patents)

Location History:

Wiesbaden, DE (2016 - 2017)
Göttingen, DE (2016 - 2017)
Ludwigshafen, DE (2015 - 2018)

Company Filing History:

11 out of 167

Abbvie Deutschland Gmbh and Co Kg

where one patent can have more than one assignee

Years Active: 2015-2018

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10100048 - Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors (2018-10-16),

2. 9862704 - Oxindole derivatives carrying an amine-substituted piperidyl-acetidinyl substituent and use thereof for treating vasopressine-related diseases (2018-01-09),

3. 9840495 - Oxindole derivatives carrying a piperidyl-substituted azetidinyl substituent and use thereof for treating vasopressine-related diseases (2017-12-12),

4. 9688678 - Oxindole compounds carrying a nitrogen-bound spiro substituent and use thereof for treating vasopressin-related diseases (2017-06-27),

5. 9657002 - Oxindole derivatives carrying an oxetane substituent and use thereof for treating vassopressin-related diseases (2017-05-23),

6. 9617226 - Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases (2017-04-11),

7. 9540370 - Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors (2017-01-10),

8. 9527856 - Oxindole compounds carrying a CO-bound spiro substituent and use thereof for treating vasopressin-related diseases (2016-12-27),

9. 9273036 - Oxindole derivatives carrying an oxetane substituent and use thereof for treating vasopressine-related diseases (2016-03-01),

10. 9266855 - Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors (2016-02-23),

11. 9090592 - Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors (2015-07-28),

Title: Marcel van Gaalen - Innovative Inventor from Ludwigshafen

Introduction: Marcel van Gaalen is a renowned inventor hailing from Ludwigshafen, Germany, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Marcel van Gaalen holds several patents in the areas of renewable energy, sustainable materials, and advanced manufacturing processes, showcasing his commitment to innovation and sustainability.

Career Highlights: With a career spanning over two decades, Marcel van Gaalen has worked with leading research institutions and multinational companies to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Marcel van Gaalen has collaborated with top scientists, engineers, and entrepreneurs to bring his inventions to life, fostering a culture of creativity and excellence in the innovation ecosystem.

Conclusion: Marcel van Gaalen's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the future of technology and inspiring the next generation of inventors.